Mini-open Transforaminal Interbody Fusion for Lumbar Degenerative Disease
Abstract
Background: Minimally invasive transforaminal lumbar interbody fusion (TLIF) using percutaneous screws is commonly performed; however, data on mini-open TLIF (MO-TLIF) remain sparse. We aimed to assess the radiological and functional outcomes of single-level MO-TLIF for degenerative disc disease. Materials and Methods: Fifty seven patients underwent MO-TLIF between March 2022 and February 2024; Baseline demographics, clinical, and radiological data were recorded. The Oswestry Disability Index (ODI) and Visual Analog Scale (VAS) were obtained preoperatively, at 1 month and 1 year. Radiographs were obtained immediate post-op, at 6 weeks, 3 months, 6 months, and at 1 year. Results: The study included 57 patients (30 males, mean age: 51.2 ± 14.8 years). Comorbidities were present in 50% of patients (33.3% had hypertension; 21% had diabetes). Most surgeries were performed at L4–L5 (n = 26) and L5–S1 (n = 23). The average surgical duration was 80 ± 8 min, with an average blood loss of 88 ± 10 mL. ODI scores significantly improved from 77.6 ± 5.3 preoperatively to 47.8 ± 4.7 at 1 month, and to 12.7 ± 3.2 at 12 months (P < 0.001). VAS scores improved from 8.1 ± 0.7 preoperatively to 2.9 ± 0.7 at 1 month, and 1.0 ± 0.7 at 12 months (P < 0.001). The average hospital stay was 2.8 ± 0.7 days. No patient had misplaced pedicle screw requiring implant revision. One patient required revision surgery for residual foraminal stenosis. Conclusion: MO-TLIF is a safe and effective procedure for treating patients with degenerative disc disease and lumbar stenosis requiring lumbar fusion.
Related
- Biportal endoscopic versus minimally invasive transforaminal lumbar interbody fusion for lumbar degenerative disease: a systematic review and meta-analysis.
- Anterior Lumbar Interbody Fusion Versus Total Disc Replacement with a Viscoelastic Prosthesis for Single-Level Lumbar Degenerative Disc Disease in Young Adults: A Comparative Retrospective Cohort Study
- Cost comparison of minimally invasive transforaminal lumbar interbody fusion: experience from Nigeria and the United States
- Response to Letter to the Editor: “Individuals Over 75-Year-Old Experience Greater Revisions Following Transforaminal Lumbar Interbody Fusion (TLIF): A Propensity Matched Study”
- Midterm Clinical and Radiographic Outcomes of Transarticular Trephonic Plasty-Assisted Percutaneous Endoscopic Lumbar Interbody Fusion for Single-Level Lumbar Degenerative Disease: A Retrospective Cohort Study
BibTeX
@article{sharma2026miniopen,
title = {{Mini-open Transforaminal Interbody Fusion for Lumbar Degenerative Disease}},
author = {Amit Sharma and Vijay Savankar and Arvind Vatkar and Kshitij Chaudhary},
journal = {Indian Spine Journal},
year = {2026},
month = sep,
doi = {10.4103/isj.isj_58_25},
url = {https://doi.org/10.4103/isj.isj_58_25},
note = {CC BY-NC-SA},
}
RIS
TY - JOUR
TI - Mini-open Transforaminal Interbody Fusion for Lumbar Degenerative Disease
AU - Amit Sharma
AU - Vijay Savankar
AU - Arvind Vatkar
AU - Kshitij Chaudhary
PY - 2026
DA - 2026/09/01
JO - Indian Spine Journal
DO - 10.4103/isj.isj_58_25
UR - https://doi.org/10.4103/isj.isj_58_25
AB - Background: Minimally invasive transforaminal lumbar interbody fusion (TLIF) using percutaneous screws is commonly performed; however, data on mini-open TLIF (MO-TLIF) remain sparse. We aimed to assess the radiological and functional outcomes of single-level MO-TLIF for degenerative disc disease. Materials and Methods: Fifty seven patients underwent MO-TLIF between March 2022 and February 2024; Baseline demographics, clinical, and radiological data were recorded. The Oswestry Disability Index (ODI) and Visual Analog Scale (VAS) were obtained preoperatively, at 1 month and 1 year. Radiographs were obtained immediate post-op, at 6 weeks, 3 months, 6 months, and at 1 year. Results: The study included 57 patients (30 males, mean age: 51.2 ± 14.8 years). Comorbidities were present in 50% of patients (33.3% had hypertension; 21% had diabetes). Most surgeries were performed at L4–L5 (n = 26) and L5–S1 (n = 23). The average surgical duration was 80 ± 8 min, with an average blood loss of 88 ± 10 mL. ODI scores significantly improved from 77.6 ± 5.3 preoperatively to 47.8 ± 4.7 at 1 month, and to 12.7 ± 3.2 at 12 months (P < 0.001). VAS scores improved from 8.1 ± 0.7 preoperatively to 2.9 ± 0.7 at 1 month, and 1.0 ± 0.7 at 12 months (P < 0.001). The average hospital stay was 2.8 ± 0.7 days. No patient had misplaced pedicle screw requiring implant revision. One patient required revision surgery for residual foraminal stenosis. Conclusion: MO-TLIF is a safe and effective procedure for treating patients with degenerative disc disease and lumbar stenosis requiring lumbar fusion.
SN - 2589-5079
SN - 2589-5087
ER -